These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9315986

  • 1. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M, Westenberg H, Vandoolaeghe E, Demedts P, Wauters A, Neels H, Meltzer HY.
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M, Vandoolaeghe E, Desnyder R.
    J Affect Disord; 1996 Dec 16; 41(3):201-10. PubMed ID: 8988452
    [Abstract] [Full Text] [Related]

  • 3. [Fluoxetine: relations between plasma concentration and therapeutic effects in 32 patients with major depression and treated with 20 mg/day].
    Bourdeaux R, Pannetier P, Younos C, Desor D, Lehr PR, Capolaghi B.
    Encephale; 1998 Dec 16; 24(1):57-61. PubMed ID: 9559305
    [Abstract] [Full Text] [Related]

  • 4. Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.
    Van Hunsel F, Wauters A, Vandoolaeghe E, Neels H, Demedts P, Maes M.
    Psychiatry Res; 1996 Dec 20; 65(3):159-69. PubMed ID: 9029664
    [Abstract] [Full Text] [Related]

  • 5. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V.
    J Clin Psychiatry; 2011 Jul 20; 72(7):962-9. PubMed ID: 21034693
    [Abstract] [Full Text] [Related]

  • 6. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B, Bertschy G, Baumann P, Francois T, Vandel P, Vandel S, Sechter D, Bizouard P.
    Encephale; 1996 Jul 20; 22(3):221-7. PubMed ID: 8767051
    [Abstract] [Full Text] [Related]

  • 7. Fluoxetine in depressed patients on dialysis.
    Blumenfield M, Levy NB, Spinowitz B, Charytan C, Beasley CM, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RF.
    Int J Psychiatry Med; 1997 Jul 20; 27(1):71-80. PubMed ID: 9565715
    [Abstract] [Full Text] [Related]

  • 8. Dose proportionality of once-daily trazodone extended-release caplets under fasting conditions.
    Karhu D, Groenewoud G, Potgieter MA, Mould DR.
    J Clin Pharmacol; 2010 Dec 20; 50(12):1438-49. PubMed ID: 20173086
    [Abstract] [Full Text] [Related]

  • 9. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors.
    Pérez V, Puiigdemont D, Gilaberte I, Alvarez E, Artigas F, Grup de Recerca en Trastorns Afectius.
    J Clin Psychopharmacol; 2001 Feb 20; 21(1):36-45. PubMed ID: 11199945
    [Abstract] [Full Text] [Related]

  • 10. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA.
    Int Clin Psychopharmacol; 1997 Mar 20; 12(2):91-7. PubMed ID: 9219044
    [Abstract] [Full Text] [Related]

  • 11. Antidepressant exacerbation of spasticity.
    Stolp-Smith KA, Wainberg MC.
    Arch Phys Med Rehabil; 1999 Mar 20; 80(3):339-42. PubMed ID: 10084445
    [Abstract] [Full Text] [Related]

  • 12. Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone.
    Otani K, Mihara K, Yasui N, Ishida M, Kondo T, Tokinaga N, Ohkubo T, Osanai T, Sugawara K, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan 20; 21(1):239-44. PubMed ID: 9075270
    [Abstract] [Full Text] [Related]

  • 13. Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients.
    Mihara K, Kondo T, Suzuki A, Yasui-Furukori N, Ono S, Otani K, Kaneko S.
    Pharmacol Toxicol; 2001 May 20; 88(5):267-70. PubMed ID: 11393588
    [Abstract] [Full Text] [Related]

  • 14. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F.
    Lancet; 1997 May 31; 349(9065):1594-7. PubMed ID: 9174562
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of oral trazodone slow release following intravenous administration in depressed patients: a naturalistic study.
    Fiorentini A, Rovera C, Caldiroli A, Arici C, Prunas C, Di Pace C, Paletta S, Pozzoli SM, Buoli M, Altamura AC.
    Riv Psichiatr; 2018 May 31; 53(5):261-266. PubMed ID: 30353201
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function.
    Levy NB, Blumenfield M, Beasley CM, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RR.
    Gen Hosp Psychiatry; 1996 Jan 31; 18(1):8-13. PubMed ID: 8666216
    [Abstract] [Full Text] [Related]

  • 17. Myoclonus secondary to the concurrent use of trazodone and fluoxetine.
    Darko W, Guharoy R, Rose F, Lehman D, Pappas V.
    Vet Hum Toxicol; 2001 Aug 31; 43(4):214-5. PubMed ID: 11474735
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV, Rozova A, Gossen ER, Gibertini M.
    Psychopharmacol Bull; 2009 Aug 31; 42(4):5-22. PubMed ID: 20581790
    [Abstract] [Full Text] [Related]

  • 19. Possible trazodone potentiation of fluoxetine: a case series.
    Nierenberg AA, Cole JO, Glass L.
    J Clin Psychiatry; 1992 Mar 31; 53(3):83-5. PubMed ID: 1548249
    [Abstract] [Full Text] [Related]

  • 20. Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent.
    Mashiko H, Niwa S, Kumashiro H, Kaneko Y, Suzuki S, Numata Y, Horikoshi R, Watanabe Y.
    Psychiatry Clin Neurosci; 1999 Apr 31; 53(2):193-4. PubMed ID: 10459686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.